Cancer genetic study by QF researchers paves way for precision prevention programme

A new study by Qatar Foundation (QF) researchers from the Qatar Genome Research Consortium and Weill Cornell Medicine-Qatar (WCM-Q) has reported the first

Related Keywords

Qatar ,Qatari ,Qataris ,Michael Pellini ,Hamdi Mbarek ,Lotfi Chouchane ,Research Partnerships ,Qatar Genome Programme Research Consortium ,Qatar Genome Programme ,Qatar Foundation ,Qatar Genome Research Consortium ,Foundation Medicine Inc ,Qatar Foundation Research ,Weill Cornell Medicine Qatar ,Lancet Oncology ,Middle East ,Middle Eastern ,Genetic Medicine ,Qatar Genome ,Precision Oncology ,Cancer Germline Variation , ,